Harran Üniversitesi Tıp Fakültesi Dergisi

Harran Üniversitesi Tıp Fakültesi Dergisi

Tedavi Dekompanse Kalp Yetersizliğinde Lipit Peroksidasyonunu Azaltmaz

Yazarlar: Emin ŞAVİK, Hatice SEZEN, Hasan BİLİNÇ, Musluhittin Emre ERKUŞ, İbrahim Halil ALTIPARMAK, Yusuf SEZEN, Nurten AKSOY

Cilt 12 , Sayı 3 , 2015 , Sayfalar 342 - 347

Konular:-

Anahtar Kelimeler:Lipid Hydroperoxide,Oxidative Stress,Heart Decompensation

Özet: Background In literature, increased lipid peroxidation in heart failure (HF) has been demostrated, however, it is stil not clear in the decompensated heart failure (DHF). The aim of this study, hence, is to investigate serum lipid hydroperoxide (LOOH) levels in the DHF patients and the effect of DHF treatment on serum LOOH levels. Materials and Methods For our experiment, 50 patients, who are DHF patients admitted to coroner intensive care unit and discharged patients providing compansation after their hospitalisation, and 50 healty volunteers, whose age and gender are similar to the 50 patients, were included. After samples venupunctured from blood vessel of both these patients and healty volunteers, they were sentrifugated. Afterwards, LOOH levels were studied in the obtained serums using an enzimatical method. Results The highest LOOH levels were in CHF group, and the lowest LOOH levels were in the control group. Additionally, LOOH levels were significantly in DHF patients higher than in the the controls (p <0.0001), and were significantly higher in the CHF group compared to both the DHF and control group (p <0.0001). In the correlation analyses, LOOH levels were possitively correlated with the different parameters such as age, systolic and diastolic blood pressures, serum glucose and troponin T levels, the left ventricule diastolic and systolic diameters in the positive presence of mitral regurgitation, but negatifly correlated with the ejection fraction. Linear regression analysis showed that only glucose level among these parameters affects the LOOH levels independently. Conclusions As a result, LOOH levels elaveted in acute DHF patients. This elevation did not decrease after treatment,which provides compansation, of the hospitalized patients. 


ATIFLAR
Atıf Yapan Eserler
Henüz Atıf Yapılmamıştır

KAYNAK GÖSTER
BibTex
KOPYALA
@article{2015, title={Tedavi Dekompanse Kalp Yetersizliğinde Lipit Peroksidasyonunu Azaltmaz}, volume={12}, number={3}, publisher={Harran Üniversitesi Tıp Fakültesi Dergisi}, author={Emin ŞAVİK,Hatice SEZEN,Hasan BİLİNÇ,Musluhittin Emre ERKUŞ,İbrahim Halil ALTIPARMAK,Yusuf SEZEN,Nurten AKSOY}, year={2015}, pages={342–347} }
APA
KOPYALA
Emin ŞAVİK,Hatice SEZEN,Hasan BİLİNÇ,Musluhittin Emre ERKUŞ,İbrahim Halil ALTIPARMAK,Yusuf SEZEN,Nurten AKSOY. (2015). Tedavi Dekompanse Kalp Yetersizliğinde Lipit Peroksidasyonunu Azaltmaz (Vol. 12, pp. 342–347). Vol. 12, pp. 342–347. Harran Üniversitesi Tıp Fakültesi Dergisi.
MLA
KOPYALA
Emin ŞAVİK,Hatice SEZEN,Hasan BİLİNÇ,Musluhittin Emre ERKUŞ,İbrahim Halil ALTIPARMAK,Yusuf SEZEN,Nurten AKSOY. Tedavi Dekompanse Kalp Yetersizliğinde Lipit Peroksidasyonunu Azaltmaz. no. 3, Harran Üniversitesi Tıp Fakültesi Dergisi, 2015, pp. 342–47.